↓ Skip to main content

Angiotensin receptor-neprilysin inhibitor therapy and recurrence of atrial fibrillation after radiofrequency catheter ablation: A propensity-matched cohort study

Overview of attention for article published in Frontiers in Cardiovascular Medicine, August 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Angiotensin receptor-neprilysin inhibitor therapy and recurrence of atrial fibrillation after radiofrequency catheter ablation: A propensity-matched cohort study
Published in
Frontiers in Cardiovascular Medicine, August 2022
DOI 10.3389/fcvm.2022.932780
Pubmed ID
Authors

Youzheng Dong, Shucai Xiao, Jinwu He, Kaixin Shi, Si Chen, Deping Liu, Bin Huang, Zhenyu Zhai, Juxiang Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 17%
Other 2 11%
Student > Ph. D. Student 1 6%
Student > Master 1 6%
Researcher 1 6%
Other 0 0%
Unknown 10 56%
Readers by discipline Count As %
Medicine and Dentistry 4 22%
Immunology and Microbiology 1 6%
Economics, Econometrics and Finance 1 6%
Unknown 12 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2022.
All research outputs
#18,692,168
of 23,164,913 outputs
Outputs from Frontiers in Cardiovascular Medicine
#3,318
of 7,075 outputs
Outputs of similar age
#300,252
of 433,871 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#427
of 1,003 outputs
Altmetric has tracked 23,164,913 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,075 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,871 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,003 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.